SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (710)5/14/1998 5:49:00 PM
From: Paul S.  Respond to of 1185
 
Regretfully, prior engagements kept me from attending the AGM. However, I do understand that it was quite an informative event. It's nice to hear the reassuring comments about what we already believe to be true, that NRT has the capability to grow into a major player in the drug development arena.

Once again I apologize for my absence at the AGM, but it did afford me the opportunity to pick up some cheap stock today.

Paul



To: Edward W. Richmond who wrote (710)5/14/1998 9:14:00 PM
From: Mr. Forthright  Read Replies (1) | Respond to of 1185
 
Now that all you biotech experts are reassured by the fact that the company has a lot of drug in the (pre-clinical HA! HA!) pipeline, here's some real news to reassure everybody: at $1.50 the promoters will still be making money on their 1,000,000 cheap shares in June, but they won't sell because they believe in the LONG-term prospect of the company. Now do you all feel better?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News